BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28163024)

  • 1. Vascular endothelial growth factor-C induces osteogenic differentiation of human mesenchymal stem cells through the ERK and RUNX2 pathway.
    Murakami J; Ishii M; Suehiro F; Ishihata K; Nakamura N; Nishimura M
    Biochem Biophys Res Commun; 2017 Mar; 484(3):710-718. PubMed ID: 28163024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor-C promotes human mesenchymal stem cell migration via an ERK-and FAK-dependent mechanism.
    Ishii M; Takahashi M; Murakami J; Yanagisawa T; Nishimura M
    Mol Cell Biochem; 2019 May; 455(1-2):185-193. PubMed ID: 30443854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF-C and TGF-β reciprocally regulate mesenchymal stem cell commitment to differentiation into lymphatic endothelial or osteoblastic phenotypes.
    Igarashi Y; Chosa N; Sawada S; Kondo H; Yaegashi T; Ishisaki A
    Int J Mol Med; 2016 Apr; 37(4):1005-13. PubMed ID: 26934950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular controls of lymphatic VEGFR3 signaling.
    Deng Y; Zhang X; Simons M
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of vascular endothelial cells on osteogenic differentiation of noncontact co-cultured periodontal ligament stem cells under hypoxia.
    Wu Y; Cao H; Yang Y; Zhou Y; Gu Y; Zhao X; Zhang Y; Zhao Z; Zhang L; Yin J
    J Periodontal Res; 2013 Feb; 48(1):52-65. PubMed ID: 22905750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1β induces differentiation of human mesenchymal stem cells into osteoblasts via the Wnt-5a/receptor tyrosine kinase-like orphan receptor 2 pathway.
    Sonomoto K; Yamaoka K; Oshita K; Fukuyo S; Zhang X; Nakano K; Okada Y; Tanaka Y
    Arthritis Rheum; 2012 Oct; 64(10):3355-63. PubMed ID: 22674197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of vascular endothelial growth factor receptor 3 signaling in differentiation of mouse embryonic stem cell-derived vascular progenitor cells into endothelial cells.
    Suzuki H; Watabe T; Kato M; Miyazawa K; Miyazono K
    Blood; 2005 Mar; 105(6):2372-9. PubMed ID: 15561887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERK signaling is required for VEGF-A/VEGFR2-induced differentiation of porcine adipose-derived mesenchymal stem cells into endothelial cells.
    Almalki SG; Agrawal DK
    Stem Cell Res Ther; 2017 May; 8(1):113. PubMed ID: 28499402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pigment epithelium derived factor upregulates expression of vascular endothelial growth factor by human mesenchymal stem cells: Possible role in PEDF regulated matrix mineralization.
    Li F; Armstrong GB; Tombran-Tink J; Niyibizi C
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1106-10. PubMed ID: 27530920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulative Effect of Mir-205 on Osteogenic Differentiation of Bone Mesenchymal Stem Cells (BMSCs): Possible Role of SATB2/Runx2 and ERK/MAPK Pathway.
    Hu N; Feng C; Jiang Y; Miao Q; Liu H
    Int J Mol Sci; 2015 May; 16(5):10491-506. PubMed ID: 25961955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secreted klotho protein attenuates osteogenic differentiation of human bone marrow mesenchymal stem cells in vitro via inactivation of the FGFR1/ERK signaling pathway.
    Zhang W; Xue D; Hu D; Xie T; Tao Y; Zhu T; Chen E; Pan Z
    Growth Factors; 2015; 33(5-6):356-65. PubMed ID: 26607681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small nuclear ribonucleoprotein polypeptide N (Sm51) promotes osteogenic differentiation of bone marrow mesenchymal stem cells by regulating Runx2.
    Meng F; Xu L; Huang S; Liu Y; Hou Y; Wang K; Jiang X; Li G
    Cell Tissue Res; 2016 Oct; 366(1):155-62. PubMed ID: 27184949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Runx2 alleviates high glucose-suppressed osteogenic differentiation via PI3K/AKT/GSK3β/β-catenin pathway.
    Chen Y; Hu Y; Yang L; Zhou J; Tang Y; Zheng L; Qin P
    Cell Biol Int; 2017 Aug; 41(8):822-832. PubMed ID: 28462510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schnurri-3 regulates BMP9-induced osteogenic differentiation and angiogenesis of human amniotic mesenchymal stem cells through Runx2 and VEGF.
    Li Y; Liu Z; Tang Y; Feng W; Zhao C; Liao J; Zhang C; Chen H; Ren Y; Dong S; Liu Y; Hu N; Huang W
    Cell Death Dis; 2020 Jan; 11(1):72. PubMed ID: 31996667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotion of osteoblast differentiation in mesenchymal cells through Cbl-mediated control of STAT5 activity.
    Dieudonne FX; Sévère N; Biosse-Duplan M; Weng JJ; Su Y; Marie PJ
    Stem Cells; 2013 Jul; 31(7):1340-9. PubMed ID: 23533197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal adhesion kinase signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells.
    Salasznyk RM; Klees RF; Williams WA; Boskey A; Plopper GE
    Exp Cell Res; 2007 Jan; 313(1):22-37. PubMed ID: 17081517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of miR-222-3p activity promoted osteogenic differentiation of hBMSCs by regulating Smad5-RUNX2 signal axis.
    Yan J; Guo D; Yang S; Sun H; Wu B; Zhou D
    Biochem Biophys Res Commun; 2016 Feb; 470(3):498-503. PubMed ID: 26809090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR‑217 inhibits osteogenic differentiation of rat bone marrow‑derived mesenchymal stem cells by binding to Runx2.
    Zhu YL; Wang S; Ding DG; Xu L; Zhu HT
    Mol Med Rep; 2017 May; 15(5):3271-3277. PubMed ID: 28339007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sprouty 2, an Early Response Gene Regulator of FosB and Mesenchymal Stem Cell Proliferation During Mechanical Loading and Osteogenic Differentiation.
    Schneider AK; Cama G; Ghuman M; Hughes FJ; Gharibi B
    J Cell Biochem; 2017 Sep; 118(9):2606-2614. PubMed ID: 28387432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
    Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.